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Introduction
Cisplatin (CP) is a chemotherapeutic agent used for treat-
ment of wide variety of cancers including testicular tumors
(Duale et al., 2007), squamous cell carcinoma of head and neck
(Baur et al., 2002), small cell lung cancer (Noda et al., 2002),
ovarian cancer (Lambert and Berry, 1985) and invasive bladder
cancer (Shipley et al., 1987).
It has been shown that CP induced hepatotoxicity
(Waseem et al., 2015), nephrotoxicity (dos Santos et al., 2012;
Purena et al., 2018) and testicular degeneration (Zhang et al.,
2001). It reduced the number of epithelial cells in seminiferous
tubules, count of sperms and sperm viability after a single in-
traperitoneal injection at the dose of 7 mg/kg. b.wt in rats
(Ateşşahin et al., 2006; Sherif et al., 2014). Furthermore, Apop-
tosis of germ cells was induced in mice after a single intraperi-
toneal injection of CP of either 1, 5, or 10 mg/kg (Zhang et al.,
2001). Reactive oxygen species were implicated in the patho-
genesis of CP induced testicular degeneration (Ilbey et al.,
2009). CP increased lipid peroxidation and decreased the ac-
tivity of antioxidant enzymes (Türk et al., 2008).
Oat (Avena sativa), a cereal grain, that is concerned for its
health benefits (Xu et al., 2013) and antioxidants activity (Chen
et al., 2007). Oats contain many phytochemicals such as to-
cotrienols, phenolic acids, flavonoids, sterols and phytic acid
(Peterson, 2001). Avenanthramide (AVA) is a nitrogen contain-
ing phenolic compound described by Collins (1989). AVA is
exclusive to oats and not found in other cereal grains. AVA
represents a chief part of the total phenolic compound in oats
(Chu et al., 2013).  There are many forms of AVA. The most
common forms are AV2c, AV2f and AV2p, which are known for
their strong antioxidant activity (Emmons et al., 1999). AVA in-
creases the activity of antioxidant enzymes in liver and kidney
of rat (Ji et al., 2003). AVA has also an anti-inflammatory ac-
tivity. It was suggested that AVA decreases the production of
cytokines through inhibition of nuclear factor kappa B activa-
tion (Guo et al., 2008). Oat oil can reduce lipid peroxidase and
enhanced density, motility and morphology of sperms in mice
induced by deltamethrin (Halima et al., 2014). This study
aimed to investigate the protective effect of AVA against tes-
ticular injury induced by CP in Sprague-Dawely rats.
Materials and methods
Animals
Thirty six male adult Sprague Dawley rats (weighing 150-
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Protective Effect of Avenanthramides against Cisplatin Induced
Testicular Degeneration in Rats
Yasmin O. El-Amir1,4*, Doha Yahia2, Mohamed Samy Yousef3
This study was performed to evaluate the protective effect of Avenanthramides (AVA) against testicular
degeneration induced by cisplatin (CP) in rats. Thirty six male rats were equally divided into four groups:
Group I served as control group, group II received intraperitoneal injection of CP at a dose of 7 mg/kg
b.wt., group III received AVA (20 mg/kg b.wt.) daily for one week before injection of CP, group IV received
only AVA. Administration of CP reduced sperm count, motility and viability, testicular weight and ep-
ithelial height. CP administration increased sperm DNA damage and malondialdehyde (MDA) level. The
level of glutathione peroxidase and testosterone hormone were decreased in CP group. Severe
histopathological changes in testes of CP exposed rats were prominent. On the other hand, adminis-
tration of AVA could improve the sperm viability, sperm count and testicular weight and reduced the
degree of DNA damage in sperms. AVA reduced the level of MDA and the histopathological changes
in testes. In conclusion, AVA can reduce the oxidative stress and ameliorate the degenerative changes
in testes induced by CP.
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200 gm) were purchased from animal house, Faculty of Med-
icine, Assiut University, Egypt. The animals were left for one
week for acclimatization. Animals were kept under standard
conditions (12 hrs dark/light cycle, 22.0±3.0°C and 60% hu-
midity). Food and water were available ad libitum. This exper-
iment was conducted according to the guidelines and ethics
of animal handling and care at Assiut University, Egypt.
Chemicals
Cisplatin (1mg/ml) obtained from Mylan S.A.S., Priest,
France and AVA enriched extract was obtained from Irvene,
California, USA (C25H31F3O5S).
Experimental design
Rats were divided randomly and equally into 4 groups
(n=9 per group). Group I served as control group. Group II (CP
group) received a single intraperitoneal injection of CP at a
dose of 7mg/kg b.wt. (Ilbey et al., 2009). Group III (AVA+CP
group) received AVA at a dose of 20 mg/kg b.wt. by gastric
tube daily for one week before single intraperitoneal injection
of CP (7 mg/kg b.wt.). Group IV (AVA group) received only AVA
at a dose of 20 mg/kg b.wt. by gastric tube daily for one week. 
Blood samples were collected from three rats from each group
at 24hrs, 48hrs, and 72hrs following injection of CP in groups
II and III, and after one week in group IV. Weight of the body
was measured, then the two testes were dissected, and
weighed. Relative weight of the testes was evaluated using the
following formula:
Relative weight of testes= Weight of testes (g)/weight of the
body (g) x100 
Blood samples
Blood samples were collected by retro-orbital bleeding
into plain tubes, serum were obtained according to Coles
(1986), and used for measurement of malondialdehyde level
(MDA), glutathione peroxidase activity (GPX) and testosterone
level.
Collection of sperms
The cauda epididymis was excised, minced and incubated
in a pre-warmed petri dish containing 10 mL Hank’s balanced
salt solution at 37°C. After few minutes, the cauda epididymis
was discarded, and the recovered suspension was gently
shaken and then used for sperm analysis (Rashidi et al., 2004;
Mesbah et al., 2007). Sperms from the cauda epididymis were
used immediately for sperm analysis and acridine orange
assay. 
Evaluation of sperms
Sperm count
For sperm count, 500 μL of the recovered suspension was
diluted with formaldehyde fixative solution (10% formalin in
PBS). Approximately 10 μL from the diluted solution was trans-
ferred into a haemocytometer (Thoma, assistant
Sondheim/Rhön, Germany) and let to stand for few minutes.
Then the settled sperms were counted per 250 small squares
of a haemocytometer (Seed et al., 1996).
Sperm Viability
Viability was assessed by eosin Y staining (5% in saline).
Forty microliter samples of the fresh sperm suspension were
placed on a glass slide, mixed with 10 μL eosin and observed
under a light microscope (400x magnification). Live sperms re-
mained colorless; while, dead sperm stained by the pink color.
At least 200 sperms were counted from each sample in ten
fields of vision randomly, and the percentage of live sperms
was recorded (Björndahl et al., 2003).
Sperm Motility
Sperm motility was assessed by visual estimation (100
sperm, in duplicate) under a phase-contrast microscope at
200x magnification. Sperms were classified as: stable, motile
without progression and motile with progressive movement
(Seed et al., 1996).
Sperm DNA integrity using acridine orange staining assay
Acridine orange test (AOT) is a simple microscopic method
based on acid conditions to denaturant DNA followed by
staining with acridine orange. AO intercalates into native DNA
and the dye fluoresces green when exposed to blue light and
fluoresces yellow to red when it binds to the fragmented DNA
(Varghese et al., 2011). The assay was performed according to
Tejada et al. (1984) with some modifications; thick smears of
sperm were air dried then soaked in Carnoy’s fixative
(methanol: acetic acid 3:1) for 2 hrs. Slides were rinsed with
water then stained with AO stain [1 ml of 1% AO in distilled
water + 90 ml of 10% acetic acid + 10 ml of Na2Hpo4 (2.83 g
in 100 ml distilled water)] for 5 minutes. Then, the slides were
rinsed with deionized water and left to dry at room tempera-
ture. Slides were examined under fluorescent microscope
(Olympus BX 43, Japan) equipped with blue filter. Two- hun-
dred sperms were analyzed per slide.
Biochemical assays
Determination of serum malondialdehyde level (MDA)
Determination of serum MDA was done according to
Grotto et al. (2009) by using colorimetric kit supplied by Bio-
diagnostics (Dokki, Giza, Egypt). The assay was performed ac-
cording to the instructions of the kit, absorbance was
measured at 534 nm by spectrophotometric means (UV spec-
trophotometer, Optizen 3220 UV, Mecasys Co. Ltd, Korea).
Determination of serum glutathione peroxidase activity (GPX)
Activity of glutathione peroxidase in serum samples was
measured according to the method of Paglia and Valentine
(1967) by using test kits supplied by Bio-diagnostic (Dokki,
Giza, Egypt), the analysis was done according to the kit pro-
tocol, absorbance was measured by UV spectrophotometer
(Optizen 3220 UV, Mecasys Co. Ltd, Korea) at 340 nm.
Determination of serum testosterone level
Hormonal analysis of serum testosterone level was deter-
mined by enzyme-linked immunosorbent assay (ELISA) using
testosterone commercial kits (DRG diagnostics, GmbH, Ger-
many). A microtiter plate reader (Stat Fax - 2100, Awareness,
Technology Inc., USA) provided with printer EPSON-LX 300+
was used to read the ELISA plate.
Histopathological examination
Specimens from both testes were fixed in neutral buffered
formalin, dehydrated by alcohol, cleared by xylene and em-
bedded in paraffin blocks. The paraffin blocks were cut at 5
µm and stained with hematoxylin and eosin (H&E) according
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to Bancroft et al. (1996). Round seminiferous tubules were
elected. The height of the germinal epithelium was measured
in ten randomly selected fields of each testicle using research
microscope Axiostar plus type made by Zeiss which connected
to professional digital image analysis system. 
Statistical analysis
Data are expressed as the mean ± SE for all parameters.
The data were analyzed using the SPSS software package ver-
sion 16.0. For difference between groups, one-way analysis of
variance (ANOVA) test was performed followed by Post Hoc
Lowest Significant Difference (LSD) multiple range test. P <
0.05 and P<0.01 was considered significant compared to con-
trol.
Results
Effect on testicular weight
The relative testicular weight was significantly decreased
(P< 0.01) at 48 and 72 hrs in CP group in comparison with
control group. Co-administration of AVA improved the relative
testicular weight at 48 hrs (Fig. 1a).
Sperm parameters
Effect on sperm count
The sperm count was significantly decreased (P< 0.01) in
CP exposed groups in a time dependent manner when com-
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Table 1. Sperm parameters in control, CP, AVA+CP and AVA groups at 24 hrs, 48 hrs, and 72 hrs. 
Data are presented as Mean±SE, In each column values followed by different superscript is significant (P<0.05)
CP: Cisplatin; AVA: Avenanthramides; AO: Acridine orange test
Fig. 1. Relative weight of testes and height of germinal epithelium in control, CP, AVA+CP and AVA groups at 24 hrs, 48
hrs, and 72 hrs. (a) Relative weight of testes. (b) Height of germinal epithelium. Different letters a, b and c indicate signifi-
cance among groups.
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pared with the control group. Administration of AVA could not
modify the effect of CP at 24hrs but significantly (P< 0.01) in-
creased the sperm count at 48 and 72 hrs time points (Table
1).
Effect on sperm motility
Cisplatin reduced the sperm motility. AVA treatment could
increase the sperm motility at 24, 48 and 72 hrs (Table 1).
Effect on sperm viability
Exposure to CP for 24, 48 and 72 hrs significantly (P<0.01)
reduced the sperm viability in a time related manner. Admin-
istration of AVA significantly (P<0.05) increased the sperm vi-
ability percentage at 24, 48 and 72 hrs compared with CP
group (Table 1 and Fig. 2).
Acridine orange DNA damage assay
Exposure of rats to CP induced a significant increase in
sperm DNA damage at 24, 48 and 72 hrs (P< 0.05) indicated
by increased the number of sperms with yellow and orange
head compared with the number of sperms with undamaged
DNA that appeared with green head. Co-administration of
AVA with CP reduced the degree of DNA damage in sperms
in time dependent manner (P< 0.05) while rats exposed to
AVA only showed the same degree as control ones (Table 1
and Fig. 3).
Findings of the biochemical analyses
Serum malondialdehyde (MDA) level
Cisplatin at 72 hrs significantly increased the lipid peroxidation
expressed by increased MDA level (P< 0.01). Administration
of AVA significantly reduced the level of MDA at 24, 48 and 72
hrs (P< 0.001) (Fig. 4a).
Glutathione peroxidase level
Glutathione peroxidase level was decreased at 24 hrs (P<
0.05) and 72 hrs (P<0.01) in CP group. AVA administration was
not effective (Fig. 4b).
Serum testosterone hormone level
Testosterone hormone was decreased (P< 0.01) in all ex-
posed groups. Co-administration of AVA could not improve
the level of testosterone (Fig. 4c).
Gross pathological findings
Examination of control testes revealed normal testicular
size with no gross lesion (Fig. 5a). Administration of CP signif-
icantly decreased size of testes. Complete atrophy of testes
was observed in one rat 72 hrs following injection of CP (Fig.
5b). Co-administration of AVA resumed the weight of testes
(Fig. 5c).
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Fig. 2. Sperm viability assessed by eosin Y staining. (a) Viable sperm. (unstained head). (b) Dead sperms (stained head).
Eosin Y stain (x100). 
Fig. 3. Sperm integrity using acridine orange test (AOT). (a) Sperms with undamaged DNA showing green head. (b) Sperms
with damaged DNA indicated by yellow or orange head (arrows). 
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Histopathological findings
The testicular epithelial height was decreased at 24, 48 and
72 hrs (P<0.01) when compared with control group. AVA ad-
ministration improved the effect of CP only at 48 hrs (Fig. 1b).
Examination of control testes revealed normal tissue architec-
ture (Fig. 6a). Interstitial edema and mild testicular degenera-
tion were observed 24 hrs after injection of CP. The testicular
changes were represented by decrease in number of sper-
matogenic cells in some seminiferous tubules without empty
lumen (Fig. 6b). After 48 hrs there was severe exhaustion of
the spermatogenic epithelium. The lumen of the seminiferous
tubules was empty and most of tubules were lined with only
spermatogonia and primary spermatocytes (Fig. 6c). Sper-
matid giant cells were observed in some seminiferous tubules.
The cells were characterized by eosinophilic cytoplasm and
multiple pyknotic nuclei (Fig. 6d).  After 72 hrs, most of the
tubules were completely empty and lined only by sertoli cells
(Fig. 6e). In one case, there was a complete necrosis of the
seminiferous tubules. The tubules were filled with granular
eosinophilic debris in association with mineralization (Fig. 6f).
Administration of AVA one week before CP injection counter-
current the histopathological changes induced by CP to some
level. Most of the seminiferous tubules were normal 24 hrs
post injection of CP (Fig. 7a). Interstitial edema and mild de-
generative changes were observed 48 hrs (Fig. 7b). After
72hrs, the height of the germinal epithelium was reduced with
the presence of desquamated epithelium in the lumen of
some tubules (Fig. 7c). No changes can be observed in AVA
group (Fig. 7d).
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Fig. 4. Serum level of MDA, GPX and testosterone in control, CP, AVA+CP and AVA groups at 24 hrs, 48 hrs, and 72 hrs.
(a) MDA level. (b) GPX level. (c) Testosterone level. Different letters a, b and c indicate significance among groups.
Fig. 5. Photomicrograph of testes. (a) Control group. (b) CP group. Note, complete atrophy of the right testes (arrow). (c)
AVA+CP group. 
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Fig. 6. Photomicrograph showing control testes and histopathological changes of testes at 24 hrs, 48 hrs and 72 hrs following
injection of CP. (a) Control group. Normal testicular architecture. (b) CP group, 24 hrs following injection.  Interstitial edema
(stars). (c-d) CP group 48hrs following injection. (c) Exhaustion of spematocytes. Only few layers of spermatogenic epithelium
could be seen, spermatogonia and primary spermatocytes. (d) Formation of spermatid giant cells (arrows). (e-f) CP group 72
hrs following injection of CP.  (e) Empty seminiferous tubules lined only with spermatogonia. (f) Dead tissue in the lumen
of the seminifrous tubules and mineralization (H&E).
Fig. 7. Photomicrograph showing histopathological picture of AVA+CP group and AVA group. (a) AVA+CP group after 24
hrs. Normal seminiferous tubules. (b) AVA+CP group after 48 hrs. Interstitial edema and mild degenerative changes. (c)
AVA+CP group after 72 hrs. Necrosed tissue in the lumen of some tubules (arrow). (d) AVA group. Normal testes. (H&E).
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Discussion
Despite of the toxic effect of CP on kidney (Purena et al.,
2018), liver (Omar et al., 2016) and testes (Reddy et al., 2016),
CP is one of the most common chemotherapeutic agents
against many types of neoplasms. In the current study, in-
traperitoneal injection of CP at a dose of 7 mg/kg. b.wt. ad-
versely affected different sperm parameters when compared
with control group. These results are constant with previous
studies which found that injection of CP reduced count and
motility of sperms (Ateşşahin et al., 2006; Reddy et al., 2016).
It was shown that CP reduced testicular weight and height of
the germinal epithelium. These results were recently observed
by Singh et al. (2017b). It was reported that injection of CP at
dose of 10 mg/kg in mice induced germ cell loss and in-
creased the number of dead germ cells, which decreased the
size of the testes (Cherry et al., 2004). The reduction in sperm
count, testicular weight and height of the germinal epithelium
may be related to the severe degenerative changes of testes,
which can be demonstrated histopathologically. In the present
study, the degenerative changes caused by CP exposure were
in the form of severe exhaustion of germinal epithelium, the
presence of spermatid giant cells, which extended to complete
necrosis of some seminiferous tubules.  These results are com-
patible with previous investigators, who experienced severe
degenerative changes of testes following injection of CP (Mo-
hammadnejad, 2012; Liu et al., 2015). It was reported that
chemotherapeutic agents lead to damage of the epithelial lin-
ing seminiferous tubules and subsequently resulted in
oligospermia or azoosperemia (Ateşşahin et al., 2006). Other
investigators reported the decrease in mitosis following treat-
ment with chemotherapeutic drugs. (Khilkevich and Kurilo,
1992). In the same way, it was found that chemotherapy acts
on rapidly dividing cells and stop their division (Howell and
Shatel, 2001). The toxicity of CP can be also attributed to the
steroidogenesis suppression and the release of reactive oxy-
gen species (ROS) (Ahmed et al., 2011).
Testosterone hormone was significantly decreased in CP
group (P< 0.01). This reduction was in agreement with Ilbey
et al. (2009). It was reported that the reduction of testosterone
level resulting from the harmful effect of CP on leydig cells.
Aydiner et al. (1997) explained that the reduction of testos-
terone level after administration of 5 mg/kg.b.wt. of CP may
be attributed to the damage of Leydig cells and the reduction
in the effects of the germinal epithelium on the LH-Leydig cell
axis. Another hypothesis was reported that CP inhibits testos-
terone synthesis by the inhibition of cholesterol side-chain
cleavage enzyme (P450scc), which is responsible for the
process of steroidogenesis (García et al., 2012). 
Injection of CP showed a significant increase in sperm
DNA damage at 24, 48 and 72 hrs (P< 0.05). This result is in
agreement with results of Singh et al. (2017a) who found that
injection of CP at a dose of 7.5 mg/kg. b.wt. for four weeks in-
duced DNA fragmentation, which can be detected by ethid-
ium bromide/acridine orange staining. It was found that the
mode of action of CP is the formation of DNA adducts, which
results in DNA fragmentation (Yousef and Hussien, 2015). The
accumulation of DNA adducts following administration of CP
in a dose dependant manner was demonstrated by Hooser et
al. (2000). DNA adducts induced by CP may be accumulated
in the testes (Poirier et al., 1992).
In this study, cisplatin significantly increased MDA level at
72 hrs (P<0.01). Many authors have reported the increase of
MDA in testes following administration of CP (Said Salem et
al., 2017; Singh et al., 2017a). The increase of MDA may be re-
lated to DNA fragmentation, which has been reported in the
present study. CP also decreased GPX level at 24 hrs (P< 0.05)
and 72 hrs. These results are in agreement with previous stud-
ies (Ateşşahin et al., 2006; Salem et al., 2012; Reddy et al.,
2016). It has been reported that the decrease of GPX activity
increase the susceptibility of sperms to free radicals (Vernet et
al., 2004), as GPX antioxidant acts as a scavenger of free radi-
cals (Abd Ellah et al., 2004).
In the current study, administration of AVA at dose of 20
mg/kg b.wt, one week before injection of CP increased the
sperm count and sperm motility at 48 and 72 hrs and in-
creased the sperm viability percentage at all times compared
with CP group. AVA also improved the effect of CP on testic-
ular weight and height of testicular epithelium. AVA also re-
duced and delayed the histopathological changes induced by
CP. It was found that administration of oats oil could improve
the biochemical parameters and the histopathological
changes induced by deltamethrin in testis of mice (Halima et
al., 2014). These results may be related to the reduction of
MDA by administration of AVA, which had been reported in
the present study.  Liu et al. (2011) reported the decrease of
plasma MDA after A. Sativa extract administration for 1 month.
It has been found that A. Sativa extracts acquired antioxidant
effect in vitro by 2,2-di(4-tert-octylphenyl)-1-picrylhydrazyl
and beta carotene bleach assays (Bratt et al., 2003; Fagerlund
et al., 2009). Oat oil decreased the detrimental effect of oxygen
species, which causes sperm membrane damage (Baumber et
al., 2000). It was found that the antioxidant ability of AVA is
10–30 times more than that of phenolic compounds of oats
(Bratt et al., 2003). Hassanein and El-Amir (2017) found that
AVA significantly decreased DNA damage through its strong
antioxidant effect of AVA. The level of GPX was low in AVA+
CP group. These results were in agreement with Kaviarasan et
al. (2008), who stated that the low levels of non-enzymatic an-
tioxidants may be attributable to increased their consumption
to scavenge free radicals.
Conclusion
The present study clearly reported the degenerative
changes in testes induced by cisplatin. Co-administration of
AVA with CP ameliorates the histopathological changes and
testicular function by reduction of oxidative stress. These re-
sults can suggest the consideration of AVA as protective agent
for the male fertility during CP administration.
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